Viewing Study NCT01339104


Ignite Creation Date: 2025-12-24 @ 9:21 PM
Ignite Modification Date: 2025-12-28 @ 3:10 AM
Study NCT ID: NCT01339104
Status: COMPLETED
Last Update Posted: 2014-10-01
First Post: 2011-04-19
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Open Label Regorafenib Study to Evaluate Cardiovascular Safety Parameters, Tolerability, and Anti-tumor Activity
Sponsor: Bayer
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module